Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Scandinavian Journal of Urology and Nephrology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/00365599.1992.11690444PMID 1626202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up.

  2010cited by this paper
• Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party).

  1992cited by this paper
• Short-term moderate-dose pelvic radiotherapy of advanced bladder carcinoma. A questionnaire-based evaluation of its symptomatic effect.

  1991cited by this paper
• Clinical significance of the "palpable mass" in patients with muscle-infiltrating bladder cancer undergoing cystectomy after pre-operative radiotherapy.

  1991cited by this paper
• DNA Ploidy and S Phase Fraction in Human Bladder Cancer

  1990cited by this paper
• The epidermal growth factor receptor and the prognosis of bladder cancer

  1990cited by this paper
• The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder

  1990cited by this paper
• DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).

  1990cited by this paper
• Neodymium-YAG laser irradiation of stage T2 muscle-invasive bladder cancer. Long-term results.

  1990cited by this paper
• Human chorionic gonadotropin, neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder carcinoma.

  1990cited by this paper
• Bladder cancer: staging with CT and MR imaging.

  1989cited by this paper
• Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen.

  1989cited by this paper
• T2/T3 bladder carcinomas treated with definitive radiotherapy with emphasis on flow cytometric DNA ploidy values.

  1989cited by this paper
• Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma.

  1988cited by this paper
• M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

  1988cited by this paper
• Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report.

  1988cited by this paper
• Contrast-Enhanced Computed Tomography in Carcinoma of the Urinary Bladder

  1987cited by this paper
• Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy.

  1986cited by this paper
• Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival.

  1985cited by this paper
• Radical irradiation of T2 and T3 bladder carcinoma. A retrospective investigation.

  1985cited by this paper
• Pelvic lymphadenectomy and radical cystectomy for transitional cell carcinoma of the bladder with pelvic nodal disease.

  1985cited by this paper
• Irradiation therapy with multiple small fractions per day in urinary bladder cancer.

  1985cited by this paper
• Split‐course radiotherapy of carcinoma of the urinary bladder Stages C and D1: A Radiation Therapy Oncology Group study

  1985cited by this paper
• Status of integrated irradiation and cystectomy for bladder cancer.

  1984cited by this paper
• Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer.

  1984cited by this paper
• Adjuvant chemotherapy with doxorubicin (Adriamycin) and 5-fluorouracil in T3, NX, MO bladder cancer treated with radiotherapy.

  1983cited by this paper
• Analysis of the performance of pathologists in the grading of bladder tumors.

  1983cited by this paper
• Survival rates of patients with bladder tumours. An experience of 1744 cases (1950-1978).

  1982cited by this paper
• Survival rates of patients with bladder tumours. An experience of 1744 cases (1950-1978).

  1982cited by this paper
• Carcinoma of the urinary bladder (category T1NxM0) treated either by radium implant or by transurethral resection only.

  1981cited by this paper
• Bladder carcinoma as a systemic disease

  1979cited by this paper
• Survival following transurethral resection of bladder carcinoma.

  1977cited by this paper

• The burden of cancer attributable to dietary dioxins and dioxin-like compounds exposure in China, 2000-2020.

  2024cites this paper
• Predicting risk and loss of disability-adjusted life years (DALY) from selected disinfection byproducts in multiple water supply sources in Saudi Arabia.

  2020cites this paper
• Oncological Outcome of Primary and Secondary Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis

  2018cites this paper
• Trihalomethanes in desalinated water: Human exposure and risk analysis

  2018cites this paper
• Cancer risk assessment on trihalomethanes and haloacetic acids in drinking water of China using disability-adjusted life years.

  2014cites this paper
• Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer

  2012cites this paper
• Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States

  2008cites this paper
• Radical radiotherapy for urinary bladder cancer: treatment outcomes

  2006cites this paper
• Age and comorbidity impact surgical therapy in older bladder carcinoma patients

  2005influential citation
• Survival experience of black patients and white patients with bladder carcinoma

  2004cites this paper
• The role of pelvic lymph node dissection as a predictive and prognostic factor in bladder cancer.

  2003cites this paper
• Combination with CD/5‐FC gene therapy enhances killing of human bladder‐cancer cells by radiation

  2003cites this paper
• Selection of Patients may Limit the Generalizability of Results from Cancer Trials

  2002cites this paper
• Prospective Registration of all Patients in a Geographical Region with Newly Diagnosed Bladder Carcinomas during a Two-year Period

  2000cites this paper
• Prevention and Treatment of Urothelial Premalignant and Malignant Lesions

  2000cites this paper
• Radiotherapy in bladder cancer.

  1999cites this paper
• Treatment outcome following radiotherapy in elderly patients with bladder cancer.

  1997cites this paper
• Long-term followup of all patients with muscle invasive (stages T2, T3 and T4) bladder carcinoma in a geographical region.

  1997cites this paper
• Survival after curative treatment of muscle-invasive bladder cancer.

  1996cites this paper
• A bladder cancer multi‐institutional experience with total cystectomy for muscle‐invasive bladder cancer

  1993cites this paper